KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Lab (RKLB) Cash & Equivalents (2020 - 2025)

Rocket Lab has reported Cash & Equivalents over the past 6 years, most recently at $828.7 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $828.7 million for Q4 2025, up 205.73% from a year ago — trailing twelve months through Dec 2025 was $828.7 million (up 205.73% YoY), and the annual figure for FY2025 was $828.7 million, up 205.73%.
  • Cash & Equivalents for Q4 2025 was $828.7 million at Rocket Lab, up from $807.9 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for RKLB hit a ceiling of $828.7 million in Q4 2025 and a floor of $44846.0 in Q2 2021.
  • Median Cash & Equivalents over the past 5 years was $299.7 million (2022), compared with a mean of $378.2 million.
  • Biggest five-year swings in Cash & Equivalents: soared 1209619.93% in 2022 and later crashed 74.78% in 2023.
  • Rocket Lab's Cash & Equivalents stood at $691.0 million in 2021, then tumbled by 64.9% to $242.5 million in 2022, then plummeted by 32.99% to $162.5 million in 2023, then soared by 66.78% to $271.0 million in 2024, then soared by 205.73% to $828.7 million in 2025.
  • The last three reported values for Cash & Equivalents were $828.7 million (Q4 2025), $807.9 million (Q3 2025), and $564.1 million (Q2 2025) per Business Quant data.